SNP Genotyping and Analysis Markets

Name: SNP Genotyping and Analysis Markets
Brand: Kalorama Information
SKU: SDAD921E89FEN
Price: 3995 USD
Availability: InStock

February 2010 | 240 pages | ID: SDAD921E89FEN
Kalorama Information

US$ 3,995.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer

Checkout Later

Need Help? Ask a Question

Abstracts
Contents

Because SNPs (single nucleotide polymorphisms), are the most common type of genetic variation between human beings. These single base pair mutations at specific DNA sequence sites, can be ideal for the task of hunting for correlations between genotype and behavior or quality exhibited by a living organism.

The use of SNP analysis has spread into numerous areas in recent years. But diagnostics and pharmacogenomics are the most promising applications, and market watchers in diagnostics, pharmaceutical, biotechnology and related instrument industries will want to watch developments in SNP analysis closely.

Kalorama Information's analyst Justin Saeks has taken a detailed look into the market for DNA Sequencing Equipment, as well as Gene Expression Profiling Systems. Now, in His report SNP Genotyping and Analysis Markets he looks at SNP analysis instruments, reagents, and related software and services, providing information critical to having an understanding of the business behind this new technology:

Overview of SNPs, their Applications and Key SNP Analysis Methods
Current Market Size and Estimates of Future Growth
Impact of the GWAS 'First Round' on the Market
Estimates of Revenues by Region (North America, Europe and ROW) and By Product Type (Consumable, Instruments, Software)
Complete List of SNP-Related Deals Made Between Companies Since 2002
Exhaustive Review of Products on the Market
Market Share of Major Companies in SNP Analysis
Discussion of GOLD Database Projects, Government Involvement and Funding
Corporate Profiles
Regulatory, Technology and Industry Trends as well as;
Twelve Challenges the Market Faces and Eight Strategic Recommendations for Companies in the SNP Analysis Market

While the market is expected to create opportunities for growth, the SNP Genotyping and Analysis market is not without its challenges. The report tackles the following trends:

Rapid Rate of Product Introductions
Increased Multiplexing Creates Improved Products
End-Users Attracted to Larger-Scale SNP Platforms
Accelerating Discoveries Create Volatile Market
Diagnostic Market Holds Obstacles For New Innovations
Complexity of Biological Systems Requires Multiple Techniques
Miniaturization of Equipment and Instruments

As with all Kalorama Information publications, SNP Genotyping and Analysis Markets is the result of a primary research effort. An analyst with experience following the biotech instrument industry researching all available sources and contacting industry experts and end users to obtain real market insights. Strategic Planners, Marketing Directors, Business Development Executives are among the individuals who will benefit from this resource.

CHAPTER ONE: EXECUTIVE SUMMARY: Introduction; Market; Trends
CHAPTER TWO: OVERVIEW: SNP Analysis Methods; Definitions; Applications; Case Studies
CHAPTER THREE: INDUSTRY, TECHNOLOGY, REGULATORY TRENDS: Industry Trends; Technology Trends; Rapid Rate of Product Introductions; Increased Multiplexing Creates Improved Products; End-Users Attracted to Larger-Scale SNP Platforms; Complexity of Biological Systems Requires Multiple Techniques; Miniaturization of Equipment and Instruments; Regulatory Trends
CHAPTER FOUR: PRODUCTS: Affymetrix; Applied Biosystems (Life Technologies); Beckman Coulter; CombiMatrix; GE Healthcare; Illumina; LI-COR Biosciences; Roche Applied Science; Sequenom
CHAPTER FIVE: CONSORTIA, FUNDING, LITIGATION AND DEALS: Consortia, Initiatives; International HapMap Project; NIH Roadmap; Funding and Consortia for Sequencing; Deals; Intellectual Property and Litigation
CHAPTER SIX: MARKET ANALYSIS: Historical; Illumina as Bellwether for SNP Analysis Market; Applied Biosystems as Bellwether for RT-PCR Products; Forecast; Assumptions and Scope; Consumer SNP; Product Revenue; Competitive Analysis
CHAPTER SEVEN: CORPORATE PROFILES: Affymetrix; Applied Biosystems (ABI) (Life Technologies); Illumina
CHAPTER EIGHT: CHALLENGES AND STRATEGIC RECOMMENDATIONS: Challenges; Strategic Recommendations
TABLE OF EXHIBITS
EXECUTIVE SUMMARY: Figure 1-1: SNP Analysis Market
CHAPTER THREE: INDUSTRY, TECHNOLOGY, REGULATORY TRENDS: Table 3-1 Critical Path Opportunities List
CHAPTER FOUR: PRODUCTS: Table 4-1: Axiom Genome-Wide Array Planes SNP Content; Figure 4-1: TaqMan Assay Strategy; Figure 4-2: Beckman Coulter’s SNPstream Assay Strategy; Table 4-2 Selected SNP Products and Technologies.; Figure 4-3 Simple ProbeSequenom
CHAPTER FIVE: CONSORTIA, FUNDING, LITIGATION AND DEALS: Table 5-1: Number of Individuals in Each Subset; Table 5-2: Composition of the DNA Polymorphism Discovery Resources; Figure 5-1: Companies’ Technologies Used in First Phase of HapMap; Table 5-3: Technologies Used in Phase 1 of HapMap; Table 5-4: SNP and Sequencing Related Initiatives and Consortia, 2009; Table 5-5: Completely Sequenced Genomes in GOLD, Jan 2009; Figure 5-2 Domains of Completely Sequenced Genomes in GOLD by Year, 1999-2008 and by Category (Archae, Bacteria, Eukaryota); Figure 5-3 Number of Genome Projects by Inst., '95- Q1 '09 Cumulative; Figure 5-4 Domains of Sequenced Genomes in GOLD, Jan 2009; Table 5-6 Number of Genome Projects by Institution; Figure 5-5 Funding of Genome Projects, 2007-2009 ($M); Table 5-7: Funding Sources of Genome Projects; Figure 5-6 Human Genome Project Funding, DOE & NIH '90-'03; Table 5-7: Countries Leading Projects, '95-Q1'09; Table 5-8: SNP Projects by Category; Table 5-9: Relevance of Non-Bacterial Sequencing Projects, '95 - Q1 '09, Cum.; Figure 5-7: Disease/Conditions Associated with Projects; Figure 5-8: NHGRI Budget by Year incl. ARRA, 2006-2010 ($M); Table 5-10: 2010 Est. NHGRI Budget by Mechanism; Figure 5-9 2010 Est. NHGRI Budget by Mechanism; Figure 5-10 NHGRI Funded Large-Scale Sequencing Ctrs '07-'08; Table 5-11 SNP Related Deals, 2009; Table 5-12: SNP Related Patents
CHAPTER SIX: MARKET ANALYSIS: Figure 6-1: Illumina Total Quarterly Revenues, 2003-2009 ($M); Figure 6-2: Applied Biosystems RT-PCR / Applied Genomics Revenues, 2001-2008 ($M); Table 6-1: SNP Analysis Tools Market, 2008-2014 ($M); Figure 6-3: SNP Analysis Tools Market Revenues, 2008-2014 ($M); Table 6-4: Growth Rate for SNP Analysis Tools; Figure 6-4: SNP Analysis Tools Market Growth Rate, 2008-2014; Figure 6-5: SNP Tools Market by Region (North America, Europe, Japan, ROW); Table 6-5: SNP Tools Market by Product (Consumable, System, Software/Service); Figure 6-6: SNP Market by Product, 2008 (Systems, Services/Software, Consumables); Table 6-6: SNP Analysis Market Shares, 2008 ($M); Figure 6-7: SNP Analysis Tools Market Shares, 2008 ($M)
CHAPTER SEVEN: CORPORATE PROFILES: Figure 7-1: Affymetrix Revenues by Product Type, 2005 - 2009; Figure 7-2: Affymetrix Consumables Revenues by DNA v RNA; Figure 7-3: Illumina Revenues 2008-2009 by quarter
CHAPTER EIGHT: CHALLENGES AND STRATEGIC RECOMMENDATIONS: Figure 8-1: Cheaper Sequencing Impacts SNP Market

SNP Genotyping and Analysis Markets

More Publications

Need Help?

Ask a Question

Market Reports